• BRENTUXIMAB chembl:CHEMBL4297710 Antineoplastic

    Alternate Names:

    CAC-10
    BRENTUXIMAB VEDOTIN BRENTUXIMAB
    BRENTUXIMAB
    BRENTUXIMAB VEDOTIN
    SGN-35
    CAC10-VCMMAE
    CAC10

    Drug Info:

    FDA Approval Hodgkin lymphoma, Anaplastic large cell lymphoma
    Drug Class Therapeutic Antibodies
    (0 More Sources)

    Publications:

  • Interaction Types & Directionality:
    antibody (inhibitory)

    Interaction Info:

    Publications:

    • Version: 20-Jun-2017

    Alternate Names:
    SGN-35 Development Name
    BRENTUXIMAB Generic Name
    ADCETRIS Trade Name

    Drug Info:
    Drug Class Therapeutic Antibodies
    FDA Approval Hodgkin lymphoma, Anaplastic large cell lymphoma

    Publications:

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: